Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management.

Autor:	Bilreiro C; Radiology Department, Champalimaud Foundation, Lisbon, Portugal.; Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.; Nova Medical School, Lisbon, Portugal., Andrade L; Radiology Department, Champalimaud Foundation, Lisbon, Portugal., Santiago I; Radiology Department, Champalimaud Foundation, Lisbon, Portugal., Marques RM; Nova Medical School, Lisbon, Portugal.; Radiology Department, Hospital de S. José, Lisbon, Portugal., Matos C; Radiology Department, Champalimaud Foundation, Lisbon, Portugal.; Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.
Jazyk:	angličtina
Zdroj:	European journal of radiology open [Eur J Radiol Open] 2024 Feb 08; Vol. 12, pp. 100553. Date of Electronic Publication: 2024 Feb 08 (Print Publication: 2024).
DOI:	10.1016/j.ejro.2024.100553
Abstrakt:	Background: Pancreatic ductal adenocarcinoma (PDAC) is a common and lethal cancer. From diagnosis to disease staging, response to neoadjuvant therapy assessment and patient surveillance after resection, imaging plays a central role, guiding the multidisciplinary team in decision-planning. Review Aims and Findings: This review discusses the most up-to-date imaging recommendations, typical and atypical findings, and issues related to each step of patient management. Example cases for each relevant condition are presented, and a structured report for disease staging is suggested. Conclusion: Despite current issues in PDAC imaging at different stages of patient management, the radiologist is essential in the multidisciplinary team, as the conveyor of relevant imaging findings crucial for patient care. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2024 The Authors. Published by Elsevier Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu